https://www.selleckchem.com/pr....oducts/ldc195943-imt
We conclude by proposing several strategies to enhance γδ T cell's antiviral function, which may be used in developing therapies for COVID-19. The influence of comorbidities on the efficacy and safety of biologic therapies in psoriasis has not been rigorously explored. To assess the incremental burden of comorbidities on clinical efficacy and safety of secukinumab vs. etanercept and placebo among patients with plaque psoriasis pooled from 4 phase 3 trials. Efficacy was assessed at week 12 according to achievement of Psoriasis Are
Like
Comment
Share
